A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/585 (2006.01) A61P 15/00 (2006.01)
Patent
CA 2679520
The aim of the present invention is the use of mineralcorticoid receptor antagonists for the production of a drug for the treatment of endometriosis. The present invention particularly relates to an improved therapeutic agent against endometriosis, which has a more favorable effectiveness profile and/or profile of side effects than previously available treatment therapies. With a mineralcorticoid receptor antagonist, endometriosis can be lastingly treated without resulting in a loss of bone mass.
L'invention a pour objet l'utilisation d'antagonistes du récepteur de minéralocorticoïde pour la production d'un médicament servant au traitement de l'endométriose. L'invention concerne en particulier un agent thérapeutique amélioré contre l'endométriose présentant un profil efficacité/effet secondaire plus avantageux que les thérapies de traitement dont on dispose jusqu'à présent. Grâce à un antagoniste du récepteur de minéralocorticoïde, l'endométriose peut être traitée de façon durable sans entraîner de perte de la masse osseuse.
Fischer Oliver-Martin
Fuhrmann Ulrike
Kaufmann-Reiche Ulrike
Moeller Carsten
Schmidt Anja
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Mineralcorticoid receptor antagonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mineralcorticoid receptor antagonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mineralcorticoid receptor antagonists for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2069043